Defined Hydrogel Matrix for Reproducible Cell Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for cell culture, particularly in drug screening and organoid expansion, rely on undefined animal-derived matrices like Matrigel, which cause batch-to-batch variation and regulatory approval issues, failing to accurately capture the heterogeneity of tumor cells and patient-specific disease characteristics, leading to suboptimal drug treatment outcomes.
Innovation Solution
A method and kit using fully defined, synthetic hydrogel matrices with preselected extracellular matrix conditions that vary in biological, biophysical, and biochemical characteristics to support the growth and expansion of specific tissue types, allowing for precise drug screening and organoid formation without animal-derived components, enabling personalized medicine and regenerative applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If naturally derived 3D cell culture systems such as Matrigel are used, then cell growth support is provided, but batch-to-batch variation and undefined composition occur
Solution Approach 1:
The patent applies parameter changes by transitioning from naturally derived matrices with undefined compositions to fully defined semi-synthetic or fully synthetic hydrogel systems where all compositional parameters are precisely controlled and defined, eliminating batch-to-batch variation while maintaining cell growth support capabilities
Solution Approach 2:
The patent employs composite materials by developing hydrogel systems that combine synthetic polymer backbones with defined bioactive peptide sequences, creating materials that replicate the functional properties of natural matrices while achieving compositional precision and regulatory compliance
2Ease of operation
If animal derived matrices such as Matrigel are used, then cell culture conditions are provided, but regulatory approval for human use is prohibited
Solution Approach 1:
The patent applies the extraction principle by removing all animal-derived components from the cell culture matrix, replacing them with fully defined semi-synthetic or fully synthetic hydrogel systems that provide equivalent cell culture support without regulatory barriers for human clinical applications
Solution Approach 2:
The patent employs disposable, fully defined hydrogel systems that can be manufactured under controlled conditions without animal sources, enabling single-use applications that eliminate cross-contamination risks and regulatory approval issues associated with animal-derived materials
3Device complexity
If a single extracellular matrix condition is used, then cell culture is simplified, but tumor cell heterogeneity is not captured
Solution Approach 1:
The patent applies segmentation by dividing the cell culture system into multiple discrete wells, each containing a uniquely defined extracellular matrix condition, allowing simultaneous cultivation of tumor cells under diverse matrix environments to capture phenotypic heterogeneity while maintaining systematic organization
Solution Approach 2:
The patent employs local quality by creating spatially distinct extracellular matrix conditions in different wells of the array, where each location provides a specific combination of biochemical, biophysical, and mechanical properties tailored to elicit particular cellular responses, thereby preserving tumor heterogeneity information
4Stability of the object's composition
If fully defined semi-synthetic or fully synthetic hydrogel systems are used, then compositional precision is achieved, but system complexity increases
Solution Approach 1:
The patent applies universality by developing a platform of fully defined hydrogel systems where a core set of synthetic polymer backbones and bioactive peptide modules can be combinatorially assembled to create multiple distinct extracellular matrix conditions, achieving compositional precision without proportionally increasing overall system complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a reliable, scalable, and reproducible method for predicting drug treatment outcomes by accurately capturing tumor heterogeneity and patient-specific characteristics, overcoming the limitations of undefined matrices and enabling clinical translation.
Implementation Method 1
providing a fully defined hydrogel matrix array with discrete volumes by crosslinking
Implementation Method 2
fully defined hydrogel matrix array with discrete volumes
Data Source
AI summary
The present invention is related to a method to be performed with one tissue type, wherein a specific combination of hydrogel features has been pre-selected for the said one tissue type to be tested. The present invention is also related to a kit of parts to perform said method.